Natural ingredients from Chinese materia medica for pulmonary hypertension

被引:0
|
作者
ZHANG Jia-Rui [1 ]
OUYANG Xuan [1 ]
HOU Chi [1 ,2 ]
YANG Qi-Feng [1 ]
Wu Yingjun [3 ]
LU Wen-Ju [1 ]
LIU Chun-Li [1 ]
YANG Kai [1 ]
ZHONG Nan-Shan [1 ]
WANG Jian [1 ,4 ,5 ]
CHEN Yu-Qin [1 ]
机构
[1] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, Guangzhou Institute of Respi
[2] Section of Physiology, Division of Pulmonary, Critical Care and Sleep Medicine, University of California
[3] The Second Affiliated Hospital of Guangzhou medical university
[4] Division of Pulmonary and Critical Care Medicine, the People's Hospital of Inner Mongolia
[5] Department of Neurology, Guangzhou Women and Children's Medical Center
关键词
D O I
暂无
中图分类号
R259 [现代医学内科疾病];
学科分类号
100506 ;
摘要
Pulmonary hypertension(PH) is a severe pathophysiological condition characterized by pulmonary artery remodeling and continuous increases in pulmonary artery pressure, which may eventually develop to right heart failure and death. Although newly discovered and incredible treatment strategies in recent years have improved the prognosis of PH, limited types of effective and economical drugs for PH still makes it as a life-threatening disease. Some drugs from Chinese materia medica(CMM) have been traditionally applied in the treatment of lung diseases. Accumulating evidence suggests active pharmaceutical ingredients(APIs) derived from those medicines brings promising future for the prevention and treatment of PH. In this review, we summarized the pharmacological effects of APIs derived from CMM which are potent in treating PH, so as to provide new thoughts for initial drug discovery and identification of potential therapeutic strategies in alternative medicine for PH.
引用
收藏
页码:801 / 814
页数:14
相关论文
共 50 条
  • [31] A Study on the Uniformity in Translation of Resources of Chinese Materia Medica
    Hu, Shuangquan
    Li, Taoan
    2019 3RD INTERNATIONAL CONFERENCE ON EDUCATION, MANAGEMENT AND SOCIAL SCIENCE (EMSS 2019), 2019, : 114 - 118
  • [32] The materia medica of the intratracheal treatment of pulmonary disease.
    Campbell, C
    BRITISH MEDICAL JOURNAL, 1902, 1902 : 1233 - 1234
  • [33] FROM MATERIA MEDICA TO RATIONAL PHARMACOTHERAPY
    VANMIERT, ASJPAM
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 1984, 109 (01) : 3 - 11
  • [34] Enlightenment from WHO Pharmacovigilance in Construction of Chinese Materia Medica Pharmacovigilance System
    魏瑞丽
    谢雁鸣
    王连心
    WorldJournalofIntegratedTraditionalandWesternMedicine, 2018, 4 (03) : 40 - 47
  • [35] Chinese vegetative materia medica in a venereological treatise by Jean Astruc from 1740
    Drobnik, Jacek
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 187 : 293 - 301
  • [36] Authentication of Chinese Materia Medica Decoction Dregs, Part 1: Comparison of Morphological and Microscopic Features of Four Chinese Materia Medica Before and After Decoction
    Wong, Lailai
    Liang, Zhitao
    Chen, Hubiao
    Zhao, Zhongzhen
    MICROSCOPY RESEARCH AND TECHNIQUE, 2011, 74 (04) : 320 - 328
  • [37] Application of Connectivity Map Database to Research on Chinese Materia Medica
    Chao Lv
    Yuchong Wang
    Runhui Liu
    Weidong Zhang
    Chinese Herbal Medicines, 2016, 8 (02) : 117 - 120
  • [38] A review about industrialization of Chinese materia medica decoction pieces
    Chao, Z.
    Xiaochen, S.
    Shuyue, W.
    Xiao, S.
    Yaohui, Y.
    Fei, G.
    Lei, S.
    PHARMAZIE, 2020, 75 (11): : 540 - 547
  • [39] The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica
    Shi, Yue
    Tang, Rui
    Luo, Fangmei
    Li, Hong
    Pan, Zouxian
    Xu, Guogang
    Yang, Yongshi
    Zhao, Zuotao
    Liang, Aihua
    Wei, Ji-Fu
    Piao, Yuanlin
    Chang, Christopher
    Sun, Jin-Lyu
    Platts-Mills, Thomas A. E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (01) : 103 - 122